Academic Urology Unit, Institute of Applied Health Sciences, UK.
Health Services Research Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
BJU Int. 2021 Aug;128(2):225-235. doi: 10.1111/bju.15336. Epub 2021 Mar 28.
To understand the barriers and facilitators to single instillation of intravesical chemotherapy (SI-IVC) use after resection of non-muscle-invasive bladder cancer (NMIBC) in Scotland and England using a behavioural theory-informed approach.
In a cross-sectional descriptive study of practices at seven hospitals, we investigated care pathways, policies, and interviewed 30 urology staff responsible for SI-IVC. We used the Theoretical Domains Framework (TDF) to organise our investigation and conducted deductive thematic analyses, while inductively coding emergent beliefs.
Barriers to SI-IVC were present at different organisational levels and professional roles. In four hospitals, there was a policy to not instil SI-IVC in theatre. Six hospitals' staff reported delays in mitomycin C (MMC) ordering and/or local storage. Lack of training, skills and perceived workload affected motivation. Facilitators included access to modern instilling devices (four hospitals) and incorporating reminders in operation proforma (four hospitals). Performance targets (with audit and feedback) within a national governance framework were present in Scotland but not England. Differences in coordinated leadership, sharing best practices, and disliking being perceived as underperforming, were evident in Scotland.
High-certainty evidence shows that SI-IVC, such as MMC, after NMIBC resection reduces recurrences. This evidence underpins international guidance. The number of eligible patients receiving SI-IVC is variable indicating suboptimal practice. Improving SI-IVC adherence requires modifications to theatre instilling policies, delivery and storage of MMC, staff training, and documentation. Centralising care, with bladder cancer expert leadership and best practices sharing with performance targets, likely led to improvements in Scotland. National quality improvement, incorporating audit and feedback, with additional implementation strategies targeted to professional role could improve adherence and patient outcomes elsewhere. This process should be controlled to clarify implementation intervention effectiveness.
采用行为理论指导的方法,了解苏格兰和英格兰在非肌肉浸润性膀胱癌(NMIBC)切除术后行单次膀胱内化疗(SI-IVC)的障碍和促进因素。
在对七家医院实践的横断面描述性研究中,我们调查了护理路径、政策,并采访了 30 名负责 SI-IVC 的泌尿科工作人员。我们使用理论领域框架(TDF)组织我们的调查,并进行了演绎主题分析,同时对出现的信念进行归纳编码。
SI-IVC 的障碍存在于不同的组织层面和专业角色中。在四家医院,有一项不在手术室行 SI-IVC 的政策。六家医院的工作人员报告称,在用丝裂霉素 C(MMC)时存在延迟下医嘱和/或局部储存的问题。缺乏培训、技能和感知到的工作量影响了动机。促进因素包括使用现代灌注设备(四家医院)和在手术操作单中加入提醒(四家医院)。在苏格兰存在国家治理框架内的绩效目标(包括审核和反馈),而在英格兰则没有。在苏格兰,协调领导、分享最佳实践以及不喜欢被视为表现不佳的差异明显。
高质量证据表明,NMIBC 切除术后行 SI-IVC,如 MMC,可降低复发率。这一证据支持国际指南。接受 SI-IVC 的合格患者人数存在差异,表明实践不够理想。提高 SI-IVC 的依从性需要修改手术室灌注政策、MMC 的配送和储存、工作人员培训和文件记录。集中护理,有膀胱癌专家领导和最佳实践共享以及绩效目标,可能导致苏格兰的改善。国家质量改进,包括审核和反馈,以及针对特定专业角色的额外实施策略,可能会提高其他地区的依从性和患者结局。应进行控制以明确实施干预的效果。